
Guardant Health, Inc.
Guardant Health, Inc.(GH)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · GH · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
107
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Guardant Health, Inc.内部人在过去近12个月主要在卖出股份,卖出行为通常由预设的Rule 10b5-1计划驱动,不一定代表对公司的负面看法。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
GH 季度内部人买卖趋势
GH 内幕交易卖出 · GH 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · GH CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
GH 高管卖出股份 · GH 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 4, 2026 | Krognes Steve E. Director | Sale | 9,294 | $1.23M⚡ | Form 4 |
| Jun 3, 2026 | Joyce Meghan V. Director | Option | 8,803 | $335K | Form 4 |
| Jun 3, 2026 | Joyce Meghan V. Director | Sale | 3,516 | $445K | Form 4 |
| Jun 3, 2026 | Joyce Meghan V. Director | Option | 1,197 | $46K | Form 4 |
| Jun 3, 2026 | Joyce Meghan V. Director | Sale | 5,728 | $728K | Form 4 |
| Jun 3, 2026 | Joyce Meghan V. Director | Sale | 650 | $83K | Form 4 |
| Jun 3, 2026 | Joyce Meghan V. Director | Sale | 106 | $14K | Form 4 |
| May 31, 2026 | Krognes Steve E. Director | Option | 154 | — | Form 4 |
| May 28, 2026 | Hidalgo Medina Manuel Director | Sale | 1,000 | $130K | Form 4 |
| May 27, 2026 | Saia John G. Chief Legal Officer | Sale | 9,994 | $1.25M⚡ | Form 4 |
| May 27, 2026 | Saia John G. Chief Legal Officer | Sale | 6 | $756 | Form 4 |
| May 22, 2026 | Freeman Chris Chief Commercial Officer | Option | 24,406 | $802K | Form 4 |
| May 22, 2026 | Freeman Chris Chief Commercial Officer | Sale | 24,406 | $2.90M⚡ | Form 4 |
| May 20, 2026 | Saia John G. Chief Legal Officer | Sale | 5,632 | $593K | Form 4 |
| May 20, 2026 | Saia John G. Chief Legal Officer | Sale | 7,187 | $767K | Form 4 |
| May 20, 2026 | Saia John G. Chief Legal Officer | Sale | 7,181 | $770K | Form 4 |
| May 20, 2026 | Talasaz AmirAli Co-Chief Executive Officer · Director | Sale | 200 | $20K | Form 4 |
| May 20, 2026 | Talasaz AmirAli Co-Chief Executive Officer · Director | Sale | 900 | $92K | Form 4 |
| May 20, 2026 | Talasaz AmirAli Co-Chief Executive Officer · Director | Sale | 1,366 | $142K | Form 4 |
| May 20, 2026 | Talasaz AmirAli Co-Chief Executive Officer · Director | Sale | 11,919 | $1.25M⚡ | Form 4 |
| May 20, 2026 | Talasaz AmirAli Co-Chief Executive Officer · Director | Sale | 1,200 | $127K | Form 4 |
| May 20, 2026 | Talasaz AmirAli Co-Chief Executive Officer · Director | Sale | 21,171 | $2.27M⚡ | Form 4 |
| May 20, 2026 | Talasaz AmirAli Co-Chief Executive Officer · Director | Sale | 33,069 | $3.57M⚡ | Form 4 |
| May 20, 2026 | Talasaz AmirAli Co-Chief Executive Officer · Director | Sale | 9,852 | $1.07M⚡ | Form 4 |
| May 20, 2026 | Talasaz AmirAli Co-Chief Executive Officer · Director | Sale | 28,908 | $3.18M⚡ | Form 4 |
Talasaz AmirAli
Co-Chief Executive Officer · Director
日期
May 20
股数
200
均价
$100.95
总金额
$20K
Talasaz AmirAli
Co-Chief Executive Officer · Director
日期
May 20
股数
900
均价
$102.57
总金额
$92K
Talasaz AmirAli
Co-Chief Executive Officer · Director
日期
May 20
股数
1,366
均价
$103.82
总金额
$142K
Talasaz AmirAli
Co-Chief Executive Officer · Director
日期
May 20
股数
11,919
均价
$105.01
总金额
$1.25M ⚡
Talasaz AmirAli
Co-Chief Executive Officer · Director
日期
May 20
股数
1,200
均价
$105.88
总金额
$127K
Talasaz AmirAli
Co-Chief Executive Officer · Director
日期
May 20
股数
21,171
均价
$106.99
总金额
$2.27M ⚡
Talasaz AmirAli
Co-Chief Executive Officer · Director
日期
May 20
股数
33,069
均价
$108.11
总金额
$3.57M ⚡
Talasaz AmirAli
Co-Chief Executive Officer · Director
日期
May 20
股数
9,852
均价
$108.97
总金额
$1.07M ⚡
Talasaz AmirAli
Co-Chief Executive Officer · Director
日期
May 20
股数
28,908
均价
$110.10
总金额
$3.18M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 GH 内幕交易
GH 内幕交易
Guardant Health, Inc.(GH)内幕交易数据来源于公司内部人(包括Talasaz AmirAli (Co-Chief Executive Officer · Director), Saia John G. (Chief Legal Officer), Freeman Chris (Chief Commercial Officer))提交的SEC Form 4申报文件。过去12个月内,5位内部人向SEC提交了交易申报。GH内部人近期主要在卖出,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看Guardant Health, Inc.机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
GH 内幕交易 · 5个问题Guardant Health, Inc.(GH)的内部人包括高管和董事,如Talasaz AmirAli (Co-Chief Executive Officer · Director), Saia John G. (Chief Legal Officer), Freeman Chris (Chief Commercial Officer)等。过去12个月内,5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026